Cronos Group Inc vs Materials Select Sector SPDR Fund — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Materials Select Sector SPDR Fund trades at $50.63. The key difference: Materials Select Sector SPDR Fund is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals.
| CRON | XLB | |
|---|---|---|
Market Cap | $1.02B | — |
Sector | Health | — |
52-Week High | $3.27 | $53.62 |
52-Week Low | $1.95 | $42.23 |
Enterprise Value | $203.29M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
XLB trades at $50.58, down 0.61% with bearish technical signals from moving averages. The materials ETF faces mixed sentiment as recent sector gains appear priced in, though infrastructure trends provide underlying support. Key support sits at $50 with resistance at $51. Recent analysis suggests limited near-term upside despite sector tailwinds from manufacturing and energy security themes.
Outlook remains cautious with technical indicators favoring bearish momentum. The materials sector benefits from infrastructure spending but faces geopolitical sensitivity and valuation concerns after recent gains. Investment opportunity exists for long-term exposure to industrial materials, though current entry timing appears suboptimal given technical weakness and priced-in cyclical recovery.
Trailing returns across standard periods
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →